CARDIO DIAGNOSTICS
Cardio Diagnostics makes heart disease prevention and early detection more accessible, personalized, and precise. Cardio Diagnostics transforms heart disease prevention through ML/AI and DNA-based solutions. Founded in 2017, Cardio Diagnostics is based in Coralville, Iowa, United States.
CARDIO DIAGNOSTICS
Industry:
Biotechnology Health Care Medical
Founded:
2017-01-01
Address:
Coralville, Iowa, United States
Country:
United States
Website Url:
http://www.cardiodiagnosticsinc.com
Status:
Active
Contact:
6317965412
Email Addresses:
[email protected]
Similar Organizations
Kellsa Diagnostics
Kellsa Diagnostics are research, development, production and marketing of healthcare products and equipment, in particular diagnostics.
Current Employees Featured
Founder
Official Site Inspections
http://www.cardiodiagnosticsinc.com
- Host name: 104.21.16.71
- IP address: 104.21.16.71
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago

More informations about "Cardio Diagnostics"
Precision Cardiovascular Medicine
Our team includes pioneers in the fields of AI and epigenetics, world-class scientists, clinicians, and technologists. Our deep understanding of cardiovascular medicine, molecular biology, and โฆSee details»
Cardio Diagnostics - Crunchbase Company Profile & Funding
Contact Email [email protected] Cardio Diagnostics makes heart disease prevention and early detection easier to access, personalized, and precise. Cardio Diagnostics โฆSee details»
Cardio Diagnostics Holdings, Inc. Announces Breakthrough in โฆ
Nov 20, 2023 Investors: Gene Mannheimer Investor Relations 855-226-9991 [email protected] Media & Public Relations: Khullani Abdullahi โฆSee details»
Cardio Diagnostics Holdings - Overview, News & Similar
Apr 29, 2024 Cardio Diagnostics Holdings contact info: Phone number: (855) 226-9991 Website: www.cardiodiagnosticsinc.com What does Cardio Diagnostics Holdings do? Cardio โฆSee details»
Cardio Diagnostics Holdings, Inc. Unveils Groundbreaking โฆ
Jan 4, 2024 The Companyโs most recent heart disease fair for an employer organization gained participation from 75% of eligible employees and their spouses. Enhanced Risk Mitigation for โฆSee details»
Cardio Diagnostics Holdings, Inc. (CDIO) - Yahoo Finance Canada
Description . Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic โฆSee details»
Cardio Diagnostics Holdings, Inc. to List on Nasdaq Following ...
Oct 26, 2022 Media & Public Relations: Khullani Abdullahi 651-208-9323 [email protected] Contacts Investors: Meesha Dogan, Ph.D. CEO 855-226-9991 โฆSee details»
CORRECTING and REPLACING Cardio Diagnostics Holdings, Inc.
Jan 4, 2024 The Companyโs most recent heart disease fair for an employer organization gained participation from 75% of eligible employees and ... Khullani Abdullahi 855-226-9991 โฆSee details»
Cardio Diagnostics Holdings, Inc Welcomes Dr. Damon Broyles, โฆ
Mar 8, 2023 CHICAGO โ Cardio Diagnostics Holdings, Inc (Nasdaq: CDIO), an artificial intelligence-powered precision cardiovascular medicine company, today announced Dr. โฆSee details»
CardioDiagnostics - Crunchbase Company Profile & Funding
CardioDiagnostics is a medical technology company specialized in cardiac care solutions. Established in USA with global R&D offices, the company develops proprietary technologies โฆSee details»
Cardio Diagnostics Holdings, Inc. (CDIO) - Stock Analysis
5 days ago Website https://cardiodiagnosticsinc.com. Full Company Profile. Financial Performance. In 2023, CDIO's revenue was $17,065, an increase of 1696.32% compared to โฆSee details»
Cardio Diagnostics Holdings, Inc. Accelerates Cardiac Care โฆ
Jan 24, 2024 CHICAGO โ Cardio Diagnostics Holdings, Inc. (Nasdaq: CDIO), an AI-driven precision cardiovascular medicine company, today announced the appointment of Dr. Vimal โฆSee details»
Cardio Diagnostics Holdings, Inc. Announces Breakthrough in
Nov 20, 2023 Investors: Gene Mannheimer Investor Relations 855-226-9991 [email protected] Media & Public Relations: Khullani Abdullahi โฆSee details»
CORRECTING and REPLACING Cardio Diagnostics Holdings, Inc.
CHICAGO, January 04, 2024--Cardio Diagnostics has unveiled HeartRisk, the Company's groundbreaking employer cardiovascular disease risk intelligence platform.See details»
Cardio Diagnostics Holdings, Inc Launches New Lab and โฆ
Oct 12, 2023 Investors: Gene Mannheimer Investor Relations 855-226-9991 [email protected] Media & Public Relations: Khullani Abdullahi 855-226 โฆSee details»
Cardio Diagnostics to Present at the Benchmark Company's โฆ
Nov 21, 2022 CHICAGO โ Cardio D iagnostics Holdings Inc (Nasdaq: CDIO) today announced it would be presenting at the Benchmark Companyโs 11 th Annual Discovery One-on-One โฆSee details»
Cardio Diagnostics Holdings Inc Launches Revolutionary Blood โฆ
Feb 28, 2023 Investors: Gene Mannheimer Investor Relations 855-226-9991 [email protected] Media & Public Relations: Khullani Abdullahi โฆSee details»
Cardio Diagnostics Holdings Inc Launches Revolutionary Blood
Feb 28, 2023 Investors: Gene Mannheimer Investor Relations 855-226-9991 [email protected] Media & Public Relations: Khullani Abdullahi โฆSee details»
Cardio Diagnostics Holdings, Inc. Achieves SOC 2 Type I โฆ
Jun 10, 2024 Investors: Gene Mannheimer Investor Relations 855-226-9991 [email protected] Media & Public Relations: Khullani Abdullahi 855-226 โฆSee details»
Cardio Diagnostics Wins โClinical Diagnostics Solution of the Year ...
CHICAGO, October 27, 2021 โ Cardio Diagnostics, Inc., a biotechnology company making cardiovascular disease prevention and early detection more accessible, personalized and โฆSee details»